Allan L. Goldstein - 30 Jun 2021 Form 4 Insider Report for REGENERX BIOPHARMACEUTICALS INC

Role
Director
Signature
/s/ Andrew Nick as Attorney-in-Fact for Allan Goldstein, Ph.D. pursuant to Power of Attorney previously filed.
Issuer symbol
RGRX on OTC
Transactions as of
30 Jun 2021
Net transactions value
+$25,000
Form type
4
Filing time
06 Jul 2021, 16:34:27 UTC
Next filing
04 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGRX Common Stock Purchase $25,000 +125,000 +8.3% $0.2000* 1,637,793 30 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGRX Series A Common Stock Warrant (right to buy) Purchase $0 +93,750 $0.000000 93,750 30 Jun 2021 Common Stock 93,750 $0.2400 Direct
transaction RGRX Series B Common Stock Warrant (right to buy) Purchase $0 +93,750 $0.000000 93,750 30 Jun 2021 Common Stock 93,750 $0.2800 Direct
holding RGRX Stock Option (right to buy) 250,000 30 Jun 2021 Common Stock 250,000 $0.3600 Direct F1
holding RGRX Stock Option (right to buy) 200,000 30 Jun 2021 Common Stock 200,000 $0.6400 Direct F1
holding RGRX Stock Option (right to buy) 150,000 30 Jun 2021 Common Stock 150,000 $0.2800 Direct F1
holding RGRX Stock Option (right to buy) 250,000 30 Jun 2021 Common Stock 250,000 $0.2100 Direct F2
holding RGRX Stock Option (right to buy) 410,000 30 Jun 2021 Common Stock 410,000 $0.2100 Direct F3
holding RGRX Stock Option (right to buy) 400,000 30 Jun 2021 Common Stock 400,000 $0.3000 Direct F4
holding RGRX Convertible Promissory Note (right to buy) $2,500 30 Jun 2021 Common Stock 20,833 $0.1200 Direct
holding RGRX Convertible Promissory Note (right to buy) $2,500 30 Jun 2021 Common Stock 20,833 $0.1200 Direct
holding RGRX Convertible Promissory Note (right to buy) $5,000 30 Jun 2021 Common Stock 13,920 $0.3600 Direct
holding RGRX Common Stock Warrant (right to buy) 15,625 30 Jun 2021 Common Stock 15,625 $0.1800 Direct
holding RGRX Common Stock Warrant (right to buy) 15,625 30 Jun 2021 Common Stock 15,625 $0.1800 Direct
holding RGRX Common Stock Warrant (right to buy) 10,440 30 Jun 2021 Common Stock 10,440 $0.4500 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% vested.
F2 62,500 shares vest on each of 7/17/18, 7/17/19, 7/17/20 and 7/17/21.
F3 102,500 shares vest on each of 5/15/19, 5/15/20, 5/15/21 and 5/15/22.
F4 100,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.